GABELLI FUNDS LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$9,022,000
+20881.4%
377,505
+3540.4%
0.06%
Q1 2020$43,000
-14.0%
10,3700.0%0.00%
Q4 2019$50,000
-20.6%
10,3700.0%0.00%
Q3 2019$63,000
-6.0%
10,3700.0%0.00%
Q2 2019$67,000
-9.5%
10,3700.0%0.00%
Q1 2019$74,000
+48.0%
10,3700.0%0.00%
Q4 2018$50,000
-34.2%
10,3700.0%0.00%
Q3 2018$76,000
+15.2%
10,3700.0%0.00%
Q2 2018$66,000
+17.9%
10,3700.0%0.00%
Q1 2018$56,00010,3700.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 2,730,000$11,384,0002.77%
CADIAN CAPITAL MANAGEMENT, LP 5,017,483$20,923,0001.28%
Ghost Tree Capital, LLC 500,000$2,085,0000.49%
Bellevue Group AG 773,677$3,226,0000.34%
NEEDHAM INVESTMENT MANAGEMENT LLC 180,000$750,0000.20%
Penn Capital Management Company, LLC 543,715$2,267,0000.16%
HighTower Advisors, LLC 2,355,942$9,826,0000.08%
Granite Investment Partners, LLC 215,760$900,0000.06%
WRAPMANAGER INC 39,547$165,0000.05%
Alyeska Investment Group, L.P. 1,563,881$6,521,0000.05%
View complete list of GENMARK DIAGNOSTICS INC shareholders